Investing.com -- Viking Therapeutics (NASDAQ: VKTX) stock fell 21% Tuesday morning despite announcing positive Phase 2 trial results for its oral obesity drug that showed significant weight loss in ...

(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially ...

Citing a $319 million budget shortfall, the state health department is implementing a minimum 3% rate reduction across all providers, the agency said.

Women between the ages of 50 and 64 use medications the most. Nearly 12% of people in the United States have taken GLP-1 medications for weight loss, with usage especially common among women ages 50 ...

Using GLP-1 drugs for weight loss is considered safe but can come with a loss of lean muscle mass. It’s crucial to do ...

Most people have likely heard about the new weight-loss and diabetes management drugs called Ozempic and Mounjaro, which are ...

Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care ...

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.

Physicians detail five practical measures to optimize GLP-1 therapy and prevent muscle loss in patients undergoing weight reduction.

Here’s everything you need to know about the new GLP-1 receptor agonist that could rival Ozempic. What is MariTide, and how does it support weight loss?